Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Are Large Language Models amplifying bias in medical science?
ABSTRACT
Large Language Models (LLMs) offer unprecedented efficiency across medical research, yet current evaluation focuses almost exclusively on output accuracy, neglecting critical issues of fairness, bias, and global representation. Because LLMs retrieve from and synthesize an evidence base already skewed toward high-income populations, their widespread adoption creates a feedback loop of recursive amplification that repeatedly surfaces dominant data while filtering out novel hypotheses and evidence from under-researched groups. Even if individual outputs remain factually accurate, this process risks creating an artificial scientific consensus that fails to reflect global health needs. Because standard disclosure rules cannot track how AI alters the broader literature landscape, evaluation paradigms must shift from checking study-level accuracy to measuring field-level representation. Establishing longitudinal literature-surveillance frameworks to monitor distributional skew, source diversity, and demographic representation, alongside strict reporting standards for model usage, is essential to prevent LLMs from exacerbating structural health inequities and undermining scientific validity.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.